Clinical trial

The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

NCT06243536

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-02-01

PhasePHASE4

Study timeline

Study start (estimated)2024-02-01Date precision: day

Registry last updated2024-02-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Overweightunresolved

Disordered Eating Behaviorsunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

standard of careDRUG

Sponsors & collaborators

University Hospital Sestre Milosrdnicelead sponsor

University of Zagrebcollaborator

Mapped research locations

ZagrebCroatia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06243536 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.